What an abandoned heart failure trial says about ‘breakthrough’ devices that don’t reach patients Majority of devices in the FDA’s breakthrough program aren’t authorized. It’s rare to learn why

https://www.statnews.com/2026/06/24/fda-breakthrough-devices-what-we-learned-livanova-vitaria-results/ By Katie PalmerJune 24, 2026 Health Tech Correspondent